Use of gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer for routine clinical practice

被引：0
|
作者：
Bendel, J [1 ]
Häusler, J [1 ]
Korfee, S [1 ]
Antoch, G [1 ]
Gauler, T [1 ]
Eberhardt, W [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Gefitinib ('Iressa', ZD1839) in relapsed non-small-cell lung cancer
    Reck, M
    Gatzemeier, U
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S33
  • [2] Gefitinib ('Iressa', ZD1839) as treatment for non-small-cell lung cancer
    Razis, E
    Papadopoulos, S
    Skarlos, D
    Exarchakos, M
    Christodoulou, C
    Karina, M
    Xylouri, M
    Labropoulos, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [3] Gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer patients progressed to chemotherapy
    Cortes-Funes, H
    Figueiras, MC
    Martín-Algarra, S
    Salinas, P
    Massutí, B
    Gascón, P
    Rosell, R
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S27 - S27
  • [4] Efficacy of gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer metastatic to the brain
    Diaz-Cantón, E
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28
  • [5] Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer
    Hotta, K
    Kiura, K
    Ueoka, H
    Tabata, M
    Fujiwara, K
    Kozuki, T
    Okada, T
    Hisamoto, A
    Tanimoto, M
    [J]. LUNG CANCER, 2004, 46 (02) : 255 - 261
  • [6] Gefitinib ('Iressa', ZD1839) in heavily pretreated patients with metastatic non-small-cell lung cancer
    Martín-Algarra, S
    Gurpide, A
    Lopez-Picazo, JM
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S30 - S30
  • [7] Efficacy of gefitinib ('Iressa', ZD1839) in a patient with advanced non-small-cell lung cancer with metastatic spread to the brain
    Petruzelka, L
    Zemanova, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [8] Gefitinib ('Iressa', ZD1839) given in the 'Iressa' Expanded Access Programme in patients with non-small-cell lung cancer
    Chioni, A
    Barbieri, F
    Baldini, E
    Orlandini, C
    Ricci, S
    Conte, PF
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S27
  • [9] Rapid symptom improvement in a patient with non-small-cell lung cancer given gefitinib ('Iressa', ZD1839)
    Martínez, JL
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S30 - S31
  • [10] Regression of metastatic non-small-cell lung cancer in a chemonaive patient treated with gefitinib ('Iressa', ZD1839)
    Petruzelka, L
    Zemanova, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
12345